Covishield, Covaxin are safest of Covid-19 vaccines, side-effects are negligible: VK Paul
Tuesday, 12 January 2021 () Covishield and Covaxin, the two Covid-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday and noted that the two "are safest of the vaccines".
Several states in India received the vaccine doses on January 12. Consignment of Covishield was dispatched from Serum Institute of India, Pune. States that received vaccines on January 12 include Delhi, Gujarat, West Bengal, Karnataka, Tamil Nadu, Odisha, Uttar Pradesh, Punjab, and others. The...
Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.
Health and Family Welfare Ministry of India on January 19 said that in case of the Covaxin which has been given emergency use authorization under clinical trial mode (Covaxin), hospitalization cost would be borne by authorities. He said, "There are two vaccines. One of the two vaccines is given emergency use authorization under clinical trial mode. In a document for this vaccine, it's mentioned that if there's causal relation between immunization and adverse event weather it is severe or serious, hospitalization cost would be borne by authorities."
NITI Aayog Member (Health) Dr VK Paul on January 19 requested doctors and nurses to accept the COVID-19 vaccines with folded hands. VK Paul said, "The concerns about adverse effects and serious problems, as of now, seem to be insignificant and the data show that we are in a comfortable situation and we would like to reassure you that these two COVID-19 vaccines are safe." He further said, "We are not fulfilling our societal responsibility if a vaccine assigned to you is not being taken. The whole world is clamouring for the vaccine. I request the doctors and nurses to accept the vaccine."
NITI Aayog Member (Health) Dr VK Paul on January 19 informed that a nasal vaccine candidate has been identified against COVID-19 that could be a game-changer, if it works. He said, "A nasal vaccine candidate has been identified. It has come for consideration for phase 1 and phase 2 trials. It looks as an exciting development. If it works then it could be a game-changer. We look forward to this development."
Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe. Dr Guleria along with NITI Aayog member VK Paul were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of the nationwide roll-out of vaccination on Saturday. Talking about the experience, he said, "I am humbled to get vaccinated in the first slot and feel so proud. I hope more and more people come forward when it comes to getting vaccinated so that we can reduce mortality and prevent the spread of COVID-19 infection." Dr VK Paul said that the vaccine is safe and people should trust the scientific process. Watch the full video for more details.
Credit: HT Digital Content Duration: 03:41Published